Neurochemical alterations in schizophrenia affecting the putative receptor targets of atypical antipsychotics. Focus on dopamine (D1, D3, D4) and 5-HT2a receptors.
Harrison
P J
PJ
University Department of Psychiatry, Warneford Hospital, Oxford. paul.harrison@psychiatry.ox.ac.uk
D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001923:Brain Chemistry / Q000502:physiology*; D006801:Humans; D051381:Rats; D011954:Receptors, Dopamine / Q000737:chemistry* / Q000187:drug effects / Q000235:genetics; D011985:Receptors, Serotonin / Q000737:chemistry* / Q000187:drug effects / Q000235:genetics; D012559:Schizophrenia / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism
D014150:Antipsychotic Agents; D011954:Receptors, Dopamine; D011985:Receptors, Serotonin